eli lilly weight loss drug retatrutide just released impressive study results for retatrutide, an investigational that targets three hormones—and may deliver more weight loss than current GLP-1s. See link below ⬇️ Lilly's triple agonist achieves 16.8%

For broader context on peptide categories, see our types of peptides

Your health counts, so keep questioning and be informed

Here are some ways you can do just that: Eat more protein, fiber, healthy fats, and fermented foods

In the future, this therapy may be an effective option for adults who are struggling with obesity or excess weight, especially if previous attempts with diet and exercise alone have not led to lasting results

Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results

The author recommends consulting a doctor before taking new supplements in conjunction with weight loss medications